Home
About
Overview
Sharing Data
ORCID
Help
History (9)
The chromosome 3q25 genomic region is associated with measures of adiposity in newborns in a multi-ethnic genome-wide association study.
Hox-dependent mechanisms for establishment and maintenance of motor neuron terminal identity
Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
Familial aggregation of postpartum mood symptoms in bipolar disorder pedigrees.
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma. Cancer. 2004 Jan 01; 100(1):65-71.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Carcinoma
Dexamethasone
Drug Administration Schedule
Drug Resistance, Neoplasm
Humans
Injections, Intravenous
Male
Middle Aged
Prostate-Specific Antigen
Prostatic Neoplasms
Suramin
Survival Analysis
Treatment Outcome
authors with profiles
Mark Ratain
Theodore Karrison
Everett Vokes